PubRank

Masaru Taniguchi

Author PubWeight™ 159.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003 6.42
2 Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J Exp Med 2002 2.38
3 A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res 2006 2.05
4 Methods for detection, isolation and culture of mouse and human invariant NKT cells. Nat Protoc 2008 1.94
5 A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J Exp Med 2008 1.94
6 Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 2004 1.93
7 A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res 2005 1.84
8 The NKT cell system: bridging innate and acquired immunity. Nat Immunol 2003 1.80
9 Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur J Immunol 2003 1.75
10 Construction of an open-access database that integrates cross-reference information from the transcriptome and proteome of immune cells. Bioinformatics 2007 1.73
11 Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation. Int Immunol 2004 1.66
12 Identification of a conserved GATA3 response element upstream proximal from the interleukin-13 gene locus. J Biol Chem 2002 1.62
13 Functionally distinct NKT cell subsets and subtypes. J Exp Med 2005 1.54
14 Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines. PLoS Biol 2012 1.51
15 Generation of cloned mice by direct nuclear transfer from natural killer T cells. Curr Biol 2005 1.49
16 A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer. J Immunol 2009 1.46
17 The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4+ T cells. Nat Immunol 2011 1.41
18 Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J Exp Med 2007 1.40
19 Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys. Int Arch Allergy Immunol 2015 1.39
20 Combination therapy of in vitro-expanded natural killer T cells and alpha-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma. Cancer Sci 2009 1.37
21 IL-21-induced Bepsilon cell apoptosis mediated by natural killer T cells suppresses IgE responses. J Exp Med 2006 1.36
22 PDC-TREM, a plasmacytoid dendritic cell-specific receptor, is responsible for augmented production of type I interferon. Proc Natl Acad Sci U S A 2008 1.33
23 Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J Biol Chem 2004 1.33
24 CD8 T cell-specific downregulation of histone hyperacetylation and gene activation of the IL-4 gene locus by ROG, repressor of GATA. Immunity 2003 1.30
25 Differential role of thymic stromal lymphopoietin in the induction of airway hyperreactivity and Th2 immune response in antigen-induced asthma with respect to natural killer T cell function. Int Arch Allergy Immunol 2007 1.29
26 Natural killer T cells accelerate atherogenesis in mice. Blood 2004 1.28
27 Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. Blood 2006 1.28
28 Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. J Immunol 2002 1.27
29 Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice. J Immunol 2007 1.27
30 Role of interferon-gamma in Valpha14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs. Microbes Infect 2007 1.26
31 CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses. Proc Natl Acad Sci U S A 2003 1.26
32 Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts. Proc Natl Acad Sci U S A 2005 1.24
33 Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide. Eur J Immunol 2005 1.22
34 Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets. J Exp Med 2005 1.22
35 Type II NKT cells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance. PLoS One 2012 1.21
36 OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice. J Clin Invest 2007 1.21
37 High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. J Clin Invest 2010 1.21
38 Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy. Clin Immunol 2010 1.21
39 src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation. J Clin Invest 2003 1.19
40 CD4(+)CD25(+) T-cell development is regulated by at least 2 distinct mechanisms. Blood 2002 1.16
41 CD69-null mice protected from arthritis induced with anti-type II collagen antibodies. Int Immunol 2003 1.14
42 Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer. Cancer Immunol Immunother 2007 1.14
43 Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo. Hepatology 2003 1.10
44 Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol 2002 1.10
45 Targeted disruption of dermatopontin causes abnormal collagen fibrillogenesis. J Invest Dermatol 2002 1.10
46 During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Infect Immun 2002 1.09
47 Host-residual invariant NK T cells attenuate graft-versus-host immunity. J Immunol 2005 1.08
48 Induction of regulatory properties in dendritic cells by Valpha14 NKT cells. J Immunol 2005 1.08
49 Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in Pla2g6. Am J Pathol 2009 1.08
50 Functional roles of NKT cell in the immune system. Front Biosci 2004 1.07
51 Interleukin (IL)-4-independent maintenance of histone modification of the IL-4 gene loci in memory Th2 cells. J Biol Chem 2004 1.06
52 Role of Valpha14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of Valpha14+ NKT cells promotes the breakage of CTL tolerance. Int Immunol 2008 1.06
53 CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion. Proc Natl Acad Sci U S A 2003 1.06
54 Critical role for CXC chemokine ligand 16 (SR-PSOX) in Th1 response mediated by NKT cells. J Immunol 2007 1.05
55 Generation of functional NKT cells in vitro from embryonic stem cells bearing rearranged invariant Valpha14-Jalpha18 TCRalpha gene. Blood 2009 1.05
56 Immunoregulatory role of Jalpha281 T cells in aged mice developing lupus-like nephritis. Eur J Immunol 2007 1.04
57 Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients. Int J Cancer 2002 1.02
58 Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of valpha14 natural killer T cells in mice. Inflamm Bowel Dis 2005 1.02
59 Plasma membrane-focused proteomics: dramatic changes in surface expression during the maturation of human dendritic cells. Proteomics 2005 1.01
60 Agonist-selected T cell development requires strong T cell receptor signaling and store-operated calcium entry. Immunity 2013 1.01
61 The Pten/PI3K pathway governs the homeostasis of Valpha14iNKT cells. Blood 2006 1.00
62 Natural killer T-cells participate in rejection of islet allografts in the liver of mice. Diabetes 2006 1.00
63 An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guérin-infected mice. J Immunol 2003 1.00
64 Ultraviolet A-induced production of matrix metalloproteinase-1 is mediated by macrophage migration inhibitory factor (MIF) in human dermal fibroblasts. J Biol Chem 2003 0.99
65 The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation. Immunology 2005 0.99
66 Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis. J Immunol 2004 0.98
67 Natural killer T cell-mediated antitumor immune responses and their clinical applications. Cancer Sci 2006 0.98
68 CD28 costimulation controls histone hyperacetylation of the interleukin 5 gene locus in developing th2 cells. J Biol Chem 2004 0.97
69 Adjuvant activity mediated by iNKT cells. Semin Immunol 2009 0.97
70 CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity. Exp Dermatol 2005 0.96
71 Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide. Cancer Res 2006 0.96
72 Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus. Mol Ther 2007 0.96
73 DOCK2 is required in T cell precursors for development of Valpha14 NK T cells. J Immunol 2006 0.95
74 SHIP influences signals from CD48 and MHC class I ligands that regulate NK cell homeostasis, effector function, and repertoire formation. J Immunol 2010 0.94
75 NKT cells are relatively resistant to apoptosis. Trends Immunol 2004 0.94
76 Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J Immunol 2005 0.94
77 Invariant Valpha14 chain NKT cells promote Plasmodium berghei circumsporozoite protein-specific gamma interferon- and tumor necrosis factor alpha-producing CD8+ T cells in the liver after poxvirus vaccination of mice. Infect Immun 2005 0.92
78 CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4. Int Immunol 2006 0.92
79 Regulation of T helper type 2 cell differentiation by murine Schnurri-2. J Exp Med 2005 0.92
80 Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells. J Clin Invest 2010 0.92
81 Mesenchymal expression of Foxl1, a winged helix transcriptional factor, regulates generation and maintenance of gut-associated lymphoid organs. Dev Biol 2003 0.92
82 Invariant NKT cells are essential for the regulation of hepatic CXCL10 gene expression during Leishmania donovani infection. Infect Immun 2005 0.91
83 Minimal contribution of Valpha14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice. Microbiol Immunol 2002 0.91
84 Lymphoid enhancer factor interacts with GATA-3 and controls its function in T helper type 2 cells. Immunology 2008 0.91
85 Regulatory dendritic cells protect against allergic airway inflammation in a murine asthmatic model. J Allergy Clin Immunol 2007 0.90
86 Injury-induced suppression of effector T cell immunity requires CD1d-positive APCs and CD1d-restricted NKT cells. J Immunol 2006 0.89
87 NKT cells turn ten. Nat Immunol 2009 0.89
88 Expansion of NK cells with reduction of their inhibitory Ly-49A, Ly-49C, and Ly-49G2 receptor-expressing subsets in a murine helminth infection: contribution to parasite control. J Immunol 2002 0.89
89 Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells. Int Immunol 2010 0.89
90 Evaluation of the function of human invariant NKT cells from cancer patients using alpha-galactosylceramide-loaded murine dendritic cells. J Immunol 2006 0.89
91 Regulation of Toll-like receptor 4 expression in mouse colon by macrophage migration inhibitory factor. Histochem Cell Biol 2005 0.88
92 Human Th1 differentiation induced by lipoarabinomannan/lipomannan from Mycobacterium bovis BCG Tokyo-172. Int Immunol 2008 0.88
93 Activation of pulmonary invariant NKT cells leads to exacerbation of acute lung injury caused by LPS through local production of IFN-γ and TNF-α by Gr-1+ monocytes. Int Immunol 2010 0.87
94 Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in 2-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis. Clin Immunol 2011 0.87
95 Accumulation of activated invariant natural killer T cells in the tumor microenvironment after α-galactosylceramide-pulsed antigen presenting cells. J Clin Immunol 2012 0.87
96 Ras activation in T cells determines the development of antigen-induced airway hyperresponsiveness and eosinophilic inflammation. J Immunol 2002 0.87
97 Protective roles of B and T lymphocyte attenuator in NKT cell-mediated experimental hepatitis. J Immunol 2009 0.87
98 Successful islet transplantation to two recipients from a single donor by targeting proinflammatory cytokines in mice. Transplantation 2007 0.87
99 Expansion of lung V alpha 14 NKT cells by administration of alpha-galactosylceramide-pulsed dendritic cells. Jpn J Cancer Res 2002 0.87
100 STAT6-dependent differentiation and production of IL-5 and IL-13 in murine NK2 cells. J Immunol 2004 0.86
101 The induced regulatory T cell level, defined as the proportion of IL-10(+)Foxp3(+) cells among CD25(+)CD4(+) leukocytes, is a potential therapeutic biomarker for sublingual immunotherapy: a preliminary report. Int Arch Allergy Immunol 2010 0.86
102 Absence of the CD1 molecule up-regulates antitumor activity induced by CpG oligodeoxynucleotides in mice. J Immunol 2002 0.86
103 Dendritic cell maturation by CD11c- T cells and Valpha24+ natural killer T-cell activation by alpha-galactosylceramide. Int J Cancer 2005 0.85
104 Gamma interferon production by hepatic NK T cells during Escherichia coli infection is resistant to the inhibitory effects of oxidative stress. Infect Immun 2003 0.85
105 Valpha14 NKT cell-mediated anti-tumor responses and their clinical application. Springer Semin Immunopathol 2005 0.85
106 Impaired IFN-gamma production of Valpha24 NKT cells in non-remitting sarcoidosis. Int Immunol 2004 0.85
107 IL-4 and T cells are required for the generation of IgG1 isotype antibodies against cardiolipin. J Immunol 2002 0.84
108 Enhanced suppression of pulmonary metastasis of malignant melanoma cells by combined administration of alpha-galactosylceramide and interleukin-18. Cancer Sci 2007 0.84
109 Distinct regulatory functions of SLP-76 and MIST in NK cell cytotoxicity and IFN-gamma production. Int Immunol 2008 0.83
110 Suppression of mast cell degranulation by a novel ceramide kinase inhibitor, the F-12509A olefin isomer K1. Biochim Biophys Acta 2005 0.83
111 Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice. Eur J Immunol 2003 0.83
112 HIV-1 Nef impairs multiple T-cell functions in antigen-specific immune response in mice. Int Immunol 2011 0.83
113 Identification of CD4(-)CD8(-) double-negative natural killer T cell precursors in the thymus. PLoS One 2008 0.83
114 Activation of natural killer T cells ameliorates postinfarct cardiac remodeling and failure in mice. Circ Res 2012 0.83
115 Regulation of early T cell development by the PHD finger of histone lysine methyltransferase ASH1. Biochem Biophys Res Commun 2007 0.83
116 Cysteine-dependent immune regulation by TRX and MIF/GIF family proteins. Immunol Lett 2004 0.82
117 RCAI-8, 9, 18, 19, and 49-52, conformationally restricted analogues of KRN7000 with an azetidine or a pyrrolidine ring: Their synthesis and bioactivity for mouse natural killer T cells to produce cytokines. Bioorg Med Chem 2007 0.82
118 Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy. Int J Hematol 2012 0.82
119 Spontaneous tolerance involving natural killer T cells after hepatic grafting in mice. Transpl Immunol 2007 0.82
120 Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator. Transplantation 2003 0.82
121 Regulatory roles of NKT cells in the induction and maintenance of cyclophosphamide-induced tolerance. J Immunol 2006 0.81
122 Expression of recombination-activating gene in mature peripheral T cells in Peyer's patch. Int Immunol 2003 0.81
123 Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice. J Mol Cell Cardiol 2013 0.81
124 Prophylaxis of lipopolysaccharide-induced shock by alpha-galactosylceramide. J Leukoc Biol 2008 0.81
125 The importance of CD25+ CD4+ regulatory T cells in mouse hepatic allograft tolerance. Liver Transpl 2006 0.81
126 Palifermin mediates immunoregulatory effects in addition to its cytoprotective effects in mice with acute graft-versus-host disease. J Clin Immunol 2008 0.81
127 Functional maturation of lamina propria dendritic cells by activation of NKT cells mediates the abrogation of oral tolerance. Eur J Immunol 2008 0.81
128 TH1-biased immunity induced by exposure to Antarctic winter. J Allergy Clin Immunol 2003 0.81
129 Synthesis and biological activity of ester and ether analogues of alpha-galactosylceramide (KRN7000). Carbohydr Res 2010 0.80
130 The role of natural killer T cells in costimulation blockade-based mixed chimerism. Transpl Int 2010 0.80
131 NKT cells play a limited role in the neutrophilic inflammatory responses and host defense to pulmonary infection with Pseudomonas aeruginosa. Microbes Infect 2006 0.80
132 Prevention of acute and chronic allograft rejection by a novel retinoic acid receptor-alpha-selective agonist. Int Immunol 2004 0.79
133 Natural killer, but not natural killer T, cells play a necessary role in the promotion of an innate antitumor response induced by IL-18. Int J Cancer 2003 0.79
134 Investigation of the role of CD1d-restricted invariant NKT cells in experimental choroidal neovascularization. Biochem Biophys Res Commun 2008 0.79
135 RCAI-17, 22, 24-26, 29, 31, 34-36, 38-40, and 88, the analogs of KRN7000 with a sulfonamide linkage: their synthesis and bioactivity for mouse natural killer T cells to produce Th2-biased cytokines. Bioorg Med Chem 2008 0.78
136 Exacerbation of invasive Candida albicans infection by commensal bacteria or a glycolipid through IFN-γ produced in part by iNKT cells. J Infect Dis 2013 0.78
137 Synthesis and biological activity of hydroxylated analogues of KRN7000 (α-galactosylceramide). Carbohydr Res 2013 0.78
138 A set of genes associated with the interferon-γ response of lung cancer patients undergoing α-galactosylceramide-pulsed dendritic cell therapy. Cancer Sci 2010 0.78
139 Contrasting roles for Valpha14+ natural killer T cells in a viral model for multiple sclerosis. J Neurovirol 2008 0.78
140 Therapeutic effects and biomarkers in sublingual immunotherapy: a review. J Allergy (Cairo) 2012 0.77
141 A murine model of NKT cell-mediated liver injury induced by alpha-galactosylceramide/d-galactosamine. Virchows Arch 2005 0.77
142 Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG2I. J Exp Med 2004 0.77
143 Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors. Immunology 2006 0.77
144 Role of a NK receptor, KLRE-1, in bone marrow allograft rejection: analysis with KLRE-1-deficient mice. Blood 2004 0.77
145 T(h)1/T(h)2 cell differentiation of developing CD4 single-positive thymocytes. Int Immunol 2002 0.77
146 Pillars article: homogenous junctional sequence of the V14+ T-cell antigen receptor α chain expanded in unprimed mice. Proc. Natl. Acad. Sci. U.S.A. 1990. 87: 5248-5252. J Immunol 2014 0.76
147 A limited role of iNKT cells in controlling systemic Candida albicans infections. Jpn J Infect Dis 2012 0.76
148 Protective role for CD1d-reactive invariant natural killer T cells in cauterization-induced corneal inflammation. Invest Ophthalmol Vis Sci 2008 0.76
149 RCAI-37, 56, 59, 60, 92, 101, and 102, cyclitol and carbasugar analogs of KRN7000: their synthesis and bioactivity for mouse lymphocytes to produce Th1-biased cytokines. Bioorg Med Chem 2009 0.76
150 Beneficial effects of combined blockade of ACE and AT1 receptor on intimal hyperplasia in balloon-injured rat artery. Arterioscler Thromb Vasc Biol 2002 0.75
151 Paradoxically high resistance of natural killer T (NKT) cell-deficient mice to Legionella pneumophila: another aspect of NKT cells for modulation of host responses. J Med Microbiol 2008 0.75
152 [A specific ligand of V alpha 14 NKT cells and its presentation]. Tanpakushitsu Kakusan Koso 2003 0.75
153 RCAI-84, 91, and 105-108, ureido and thioureido analogs of KRN7000: their synthesis and bioactivity for mouse lymphocytes to produce Th1-biased cytokines. Bioorg Med Chem 2012 0.75
154 [Induction of allergic responses mediated by invariant iNKT]. Arerugi 2012 0.75
155 RCAI-61 and related 6'-modified analogs of KRN7000: their synthesis and bioactivity for mouse lymphocytes to produce interferon-γ in vivo. Bioorg Med Chem 2013 0.75
156 [The regulatory role of V alpha 14 NKT cells in innate and acquired immune response]. Tanpakushitsu Kakusan Koso 2002 0.75
157 [Species identification of animal hair present as a contaminant in food by PCR-APLP method]. Shokuhin Eiseigaku Zasshi 2012 0.75
158 [Recognition of CD1d/glycolipid antigen complex by NKT cells and mechanisms in immune regulation]. Tanpakushitsu Kakusan Koso 2008 0.75